ANO1 and prostate carcinoma: Considered together, these initial observations suggest that DNA methylation plays a critical role in down-regulating ANO1 expression and that 5-Aza-CdR treatment efficiently attenuates DNA-methylation-induced ANO1 silencing in prostate cancer cells with low metastatic potential.